CHELSEA MAUSSER: Open Payments
NPI 1861099830 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,285 in 79 payments from 15 companies in 2025. Trend: 2023 $648 · 2024 $831 · 2025 $1,285
Food & beverage: $1,285
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $403 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $249 |
| Aimmune Therapeutics, Inc. | 11 | $190 |
| Gilead Sciences, Inc. | 4 | $74 |
| Regeneron Healthcare Solutions, Inc. | 4 | $68 |
| Lilly USA, LLC | 4 | $68 |
| Janssen Biotech, Inc. | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 1 | $36 |
| QOL Medical, LLC | 2 | $31 |
| PFIZER INC. | 2 | $29 |
Products named: ZENPEP, ENTYVIO, SKYRIZI, RINVOQ, EOHILIA, DUPIXENT, LINZESS, OMVOH.
Industry payments across IA — which companies pay providers there.
